Literature DB >> 18343642

Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens.

Elisabet Jerlhag1, Emil Egecioglu, Suzanne L Dickson, Lennart Svensson, Jörgen A Engel.   

Abstract

Previously, we have reported that the orexigenic peptide ghrelin activates the cholinergic-dopaminergic reward link, involving nicotinic acetylcholine receptors (nAChR). The alpha(3)-alpha(7) and beta(2)-beta(4) subunits of the nAChR can be combined into pentameric nAChRs, with different functional roles. The present experiments show that the locomotor stimulatory effects of ghrelin, either into laterodorsal tegmental area (LDTg) or ventral tegmental area (VTA), are mediated via ventral tegmental nAChR, but neither the alpha(4)beta(2) (using dihydro-beta-erythroidine) nor the alpha(7) (using methyllycaconitine) subtypes appears to be involved. On the other hand, the alpha(3)beta(2), beta(3) and/or alpha(6) (using alpha-conotoxin MII) subtypes in the VTA mediate the stimulatory and DA-enhancing effects of ghrelin, a pattern that ghrelin shares with ethanol (n=5-8). Radioligand-binding experiments shown that ghrelin does not interfere directly with nAChRs (n=26). We therefore suggest that the alpha(3)beta(2), beta(3) and/or alpha(6) subtypes might be pharmacological targets for treatment of addictive behaviours including compulsive overeating and alcoholism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343642     DOI: 10.1016/j.euroneuro.2008.02.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  26 in total

1.  18-Methoxycoronaridine, a potential anti-obesity agent, does not produce a conditioned taste aversion in rats.

Authors:  Olga D Taraschenko; Isabelle M Maisonneuve; Stanley D Glick
Journal:  Pharmacol Biochem Behav       Date:  2010-05-10       Impact factor: 3.533

Review 2.  The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humans.

Authors:  George A Kenna; Robert M Swift; Thomas Hillemacher; Lorenzo Leggio
Journal:  Neuropsychol Rev       Date:  2012-07-07       Impact factor: 7.444

3.  Computational modeling study of human nicotinic acetylcholine receptor for developing new drugs in the treatment of alcoholism.

Authors:  Zeng-Jian Hu; Li Bai; Yousef Tizabi; William Southerland
Journal:  Interdiscip Sci       Date:  2009-11-14       Impact factor: 2.233

Review 4.  Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.

Authors:  Ke-chun Yang; Guo-zhang Jin; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

5.  Requirement of central ghrelin signaling for alcohol reward.

Authors:  Elisabet Jerlhag; Emil Egecioglu; Sara Landgren; Nicolas Salomé; Markus Heilig; Diederik Moechars; Rakesh Datta; Daniel Perrissoud; Suzanne L Dickson; Jörgen A Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

Review 6.  Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.

Authors:  Maryka Quik; Xiomara A Perez; Sharon R Grady
Journal:  Biochem Pharmacol       Date:  2011-06-13       Impact factor: 5.858

7.  Ghrelin and nicotine stimulate equally the dopamine release in the rat amygdala.

Authors:  Miklós Palotai; Zsolt Bagosi; Miklós Jászberényi; Krisztina Csabafi; Roberta Dochnal; Máté Manczinger; Gyula Telegdy; Gyula Szabó
Journal:  Neurochem Res       Date:  2013-07-09       Impact factor: 3.996

Review 8.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

9.  Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference.

Authors:  Elisabet Jerlhag; Emil Egecioglu; Suzanne L Dickson; Jörgen A Engel
Journal:  Psychopharmacology (Berl)       Date:  2010-06-19       Impact factor: 4.530

10.  Ghrelin in central neurons.

Authors:  F Ferrini; C Salio; L Lossi; A Merighi
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.